Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intermittent preventive treatment of malaria with artemisinin-based combination therapies among schoolchildren in Mali
PACTR202109827515839Phase 4Unknown
- Sponsor
- Rectorat
- Start
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of sulfadoxine + pyrimethamine, amodiaquine and artesunate in malaria (3 arms), sponsored by Rectorat. Primary endpoint: Episodes of clinical malaria. Status: unknown.
02
Drugs
sulfadoxine + pyrimethamineamodiaquineartesunate
03
Conditions
malaria
Beyond the preview
Go deeper on PACTR202109827515839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202109827515839.